Skip to main content

Table 5 Comparisons Between NAT2 Phenotypes

From: Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study

 

Controls(N = 426)

Cases(N = 545)

    

NAT2 Phenotype

n

%

n

%

OR

CI

p

q

Slow

241

56.6

299

54.9

1

-

-

-

Intermediate

161

37.8

198

36.4

0.993

0.76-1.31

0.959

0.959

Rapid

19

4.5

42

7.7

1.82

1.04-3.30

0.042a

0.084

  1. Logistic regression analysis of individual NAT2 phenotypes, adjusted for age OR = odds ratio, CI = 95% confidence intervals for ORs, p = p-value, q = q-values for multiple testing adjustment using Holm's method. aWhen intermediate and slow phenotypes are combined (due to p = 0.96) and used as reference, the p-value for rapid is 0.037, and no multiple testing correction is needed since it is a single hypothesis